This is a working overview of anti-doping, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-24. Anything still debated is marked as such rather than presented as settled.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport; not approved as medicine | Listed by WADA at all times. |
| Common synonyms | GW501516, GW-501516, endurobol | Cardarine is a colloquial name. |
| Typical analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Common test matrix | Urine | Blood and dried blood spots also possible. |
| Legal classification | Varies by country | Often treated as unapproved drug or research chemical. |
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
== External links == Media related to Protons at Wikimedia Commons Particle Data Group at LBL Large Hadron Collider Eaves, Laurence; Copeland, Ed; Padilla, Antonio (Tony) (2010). "The shrinking proton". Sixty Symbols. Brady Haran for the University of Nottingham. MIT proton visualization project: Inside the Proton, the 'Most Complicated Thing You Could Possibly Imagine', Quanta Magazine, Oct 19 2022 Visualizing the Proton, Arts at MIT, 2022
Graphene is chemically dormant, mechanically sturdy, and non-permeable to gas or liquid. So, carbon plays a major role for fabrication of nanomaterials with porous nature. Graphene membranes that are formed by graphene oxide molecules or chemically converted graphene that is adhered with 2D nano mediated arrays have the ability to efficiently separate molecules in a gas or in a liquid phase. Graphene-coated nanomembranes are said to be more applicable in water treatment due to its unique properties. Graphene membranes are obtained from vacuum filtration or coating of graphene oxide solution as Graphene oxide sheets. The graphene coated nanofiltration membrane showed a higher water flux range. The graphene embedded with carbon nanotubes to serve as nanofilters is more useful for dye rejection in water effluent, removal of salt ions, and also acts as antifouling agent. Graphene nanofilter membranes possess effective antifouling agent due to its strong bond between graphene sheets and proteins. Also, graphene oxide coated nanofilter membranes helps in dechlorination of water. In addition to this, ultrathin nanofilter coated with graphene is the most potent filter that could be commercialized for water purification. Graphene oxide membranes can be used in various forms such as free, surface modified, and graphene cast in membranes in the range of micro, nano, or ultrafilters. Among which nanofilters is more efficient for water desalination due to its mechanical strength and physiochemical properties of the membrane.
== History == The method of thermospray ionization was first introduced by a patent evidenced as early as 1983, and described in further detail by a patent published on March 8, 1988. Inventors Marvin L. Vestal and Calvin R. Blakley proposed an ion vapor source for mass spectrometry of liquids under a US Grant from the Department of Health, Education, and Welfare. The proposed method detailed a coupling device between liquid chromatographic columns and various methods of detection for gaseous samples; like mass spectrometry, electron capture, atomic adsorption, etc. Four different representations of the thermospray vaporizer were presented in the 1988 patent – UA4730111A. Nonvolatile, ionic, and thermally labile solutes were investigated with the various control systems on the vaporizers to achieve partial vaporization.
Professor Richard Hilary Templer. Lately Director of Innovation, Grantham Institute, Imperial College London. For services to Climate Innovation. Dr. Gillian Romaine Tett. Editorial Board, Financial Times. For services to Economic Journalism. Usha Ladwa-Thomas. Race Adviser, Welsh Government. For services to Black, Asian and Minority Ethnic Communities. Margaret Ann Throup, MP. Member of Parliament for Erewash. For Political and Public Service. Jane Elizabeth Toogood. Co-Chair, Hydrogen Delivery Council. For services to the Low Carbon Hydrogen Sector. Sara Louise Tough. Executive Director, Children's Services, Norfolk County Council. For services to Education and Children's Social Care. John Henry Trayner. Lately Managing Director, Go-Ahead London. For services to Transport, to Skills and to Education in London. Marcus Edward Trescothick. Mental Health Ambassador, Professional Cricketers' Association. For services to Mental Ill Health. Professor Joyce Ann Tyldesley. Professor of Egyptology, University of Manchester. For services to Egyptology and Heritage. Nicola Madeline van der Drift. Chief Executive, International Bomber Command Centre. For services to Heritage. Louise van der Straeten. Senior Lawyer, Serious Fraud Office. For services to the Administration of Justice. Vinaichandra Guduguntla Venkatesham. Chief Executive Officer, Arsenal Football Club. For services to Sport. Ewan Andrew Venters. Chief Executive, Hauser & Wirth and Chair, GREAT Private Sector Council. For services to International Trade. Robert Iain Wainwright. Founder, Doddie Aid.
Sources: en.wikipedia.org
The N-alpha amine of the C-terminal amino acid of the target peptide is protected with Fmoc or Boc group Protected amino acid is coupled with free amino groups attached to resin beads Protecting group is removed (see: Protecting groups schemes) The second amino acid with an N-protecting group is coupled with the first one. Coupling reagents facilitate peptide bond formation. The above cycle is repeated until the desired sequence has been synthesized Optionally, the N-terminal amino group undergoes capping, thereby preventing residual unreacted resin-bound peptides from further reaction The linker holding the peptide and resin together is cleaved chemically to release the peptide The crude product is purified using either: reverse-phase high-performance liquid chromatography (HPLC) multicolumn countercurrent solvent gradient purification (MCSGP) which is utilised mainly in the case of longer peptides, due to accumulation of numerous minor byproducts that have similar properties to the desired peptide product. This process is used to maximise the yield without sacrificing purity.
=== Histology === Histologically speaking, it is characterized as dense connective tissue made primarily of type 1 collagen fibers. The collagen of the sclera is continuous with the cornea. From outer to innermost, the four layers of the sclera are:
== Uses == Putrescine reacts with adipic acid to yield the polyamide nylon 46, which is marketed by Envalior (formerly DSM) under the trade name Stanyl. Due to its role in putrification, putrescine has also been proposed as a biochemical marker for determining how long a corpse has been decomposing.
==== Deka Machines ==== The Deka Machines (デカマシン, Deka Mashin) are vehicle-themed mecha that are dispatched from the Deka Base and can combine into giant robots through either Tokusou Combination (特捜合体, Tokusō Gattai) or Tokusou Transformation (特捜変形, Tokusō Henkei).
Caspar Wistar, known for advocating compulsory vaccination; Benjamin Smith Barton, a botany and Native American culture expert; and Dr. Benjamin Rush, a Declaration signatory interested in the medicinal properties of cinchona bark. Humboldt's companion, Charles Willson Peale, a painter and lay scientist, introduced him to his unique museum, dubbed the "School of Wisdom." The museum held an eclectic array of specimens, including stuffed animals, bizarre artifacts, and a collection of paintings for sale. Peale also showcased a device called the physiognotrace, which allowed individuals to trace silhouettes, and Humboldt participated in creating a series of his own profiles.
Sources: en.wikipedia.org
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.
Laboratories use liquid chromatography-tandem mass spectrometry to detect GW501516 and its metabolites. Urine is commonly tested, and testing can occur in and out of competition.
No, cardarine is not a SARM. It is a PPARδ agonist, which acts on a different receptor. The two classes are often confused in online discussions.
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.